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Abstract Four different stefin-type cysteine proteinase inhibi- tin [15,16] and of a complex of stefin B with carboxymethyl- 
tors have been isolated from porcine thymus and skin. Amino papain [17]. The reactive site of the inhibitor comprises of two 
acid sequence determination revealed the presence of stefin A and hairpin loops and the N-terminal part of the inhibitor forms a 
stefin B type inhibitors and two new inhibitors, designated as hydrophobic wedge-shaped e ge, which is highly complemen- 
porcine stefin D1 and stefin D2. Stefin D1 was identified as tary to the active site of the papain. The crystal structure of 
PLCPI ,  an inhibitor recently characterized from porcine cathepsin B differs from that of papain in having an extra 
polymorphonuclear leukocytes [Lenar~i~ et al. (1993) FEBS loop of about 20 residues that partially occludes the active 
Lett. 336, 289-292]. Stefin A is composed of 101 amino acids site cleft, thus lowering the affinity of binding the cystatin- 
and has an Mr of 11 391 while stefin B contains 98 amino acids, like protein inhibitors to cathepsin B [18] and explaining its 
has an Mr of 11 174 and is N-terminally blocked. All inhibitors dipeptidyl carboxypeptidase activity. 
were found to be fast-acting inhibitors of papain, cathepsin L and In this paper we present he purification and characteriza- 
cathepsin S (Ki =0.009-0.161 nM). Stefins A and B also bind 
tightly and rapidly to cathepsin H (Ki = 0.027 and 0.069 nM, tion from porcine tissue of stefins A and B and two new 
respectively), while stefins D1 and D2 have been shown to be very stefin-type inhibitors, designated stefins D1 and D2. The corn- 
poor inhibitors of cathepsin H (Ki = 102-150 nM). The decreased plete amino acid sequences of stefins A, B and D1 were de- 
affinity of these inhibitors toward cathepsin B (Ki = 2-1700 nM) termined and compared with other known stefin-type se- 
was shown to be mainly due to the low second order association quences. In addition, their kinetics of interaction with 
rate constants. The presence of a highly negatively charged N- papain-like cysteine proteinases were determined. 
terminus on stefin D1 constitutes a likely structural determinant 
of inhibitor specificity. 2. Materials and methods 
Key words: Cysteine proteinase inhibitor; Papain; 2.1. Enzymes 
Cathepsin; Amino acid sequence; Kinetics Papain (EC 3.4.22.2; 2 x crystallized) was from Sigma; human ca- 
thepsins B (EC 3.4.22.1) and L (EC 3.4.22.15) [19,20] and bovine 
cathepsins H (EC 3.4.22.16) and S (EC 3.4.22.27) [21,22] were purified 
as described. Glycyl endopeptidase (EC 3.4.22.25) was a gift from Dr. 
1. Introduction Alan J. Barrett (Strangeways Research Laboratories, Cambridge). 
Staphylococcus aureus strain V-8 proteinase (EC 3.4.21.19) was ob- 
tained from Miles; tx-chymotrypsin (EC 3.4.21.1; 3 × crystallized) and 
Stefins comprise one of the protein families of cysteine pro- clostripain (EC 3.4.22.8) were from Sigma. 13-Trypsin (EC 3.4.21.1) 
teinase inhibitors which belong to the cystatin superfamily was prepared according to [23]. 
[1,2]. They are low molecular weight (Mr about 11 000), sin- 
gle-chain, acidic proteins with no disulphide bonds or carbo- 2.2. Purification procedure 
hydrates [1,3]. Stefins A and B have been identified in human Inhibitors were purified from porcine thymus using a procedure 
slightly modified from that previously described for the isolation of 
tissues [4-8] and their analogues have been found in rat [9,10], human stefins A and B [8]. Affinity chromatography on Cm-papain 
bovine [11-13] and porcine tissues [14]. The stefin B inhibitor Sepharose was used as the first purification step, followed by gel 
may play a role in the regulation of proteolysis in the cytosol chromatography on Sephadex G-50 where two inhibitory peaks with 
of different issues, while stefin A probably controls the activ- Mr of about 25 000 and 12 000 were obtained. Both peaks were con- 
centrated by ultrafiltration, dialysed against 0.01 M Tris buffer, pH 
ities of cysteine proteinases predominantly in the skin [1]. The 7.4, and further purified on a DEAE-Sephacel column (2 × 26 cm) 
inhibition of mammalian cysteine proteinases, cathepsin B, H, equilibrated with the same buffer. Bound proteins were eluted with 
L and S, and some plant enzymes, such as papain and actin- a linear gradient of NaCl (0-0.25 M) in the starting buffer. Stefin B 
idin, occurs via the formation of tight and reversible qui- was eluted in the dimer form with an Mr of about 25 000 while the 
proteins with lower Mr were eluted in two major inhibitory peaks 
molar complexes between inhibitors and their target enzymes identified by sequence as stefins D1 and D2. 
[1]. Fundamental information about the nature of the binding The same purification scheme was used for the isolation of the 
has been provided from the crystal structure of chicken cysta- inhibitors from porcine skin. Only one inhibitory peak with an Mr 
of about 12 000, identified by sequence as stefin A, was obtained after 
*Corresponding author. Fax: +386 61 27 35 94. gel chromatography and ion-exchange chromatography on DEAE- 
E-mail: brigita.lenarcic@ijs.si Sephacel using a gradient of NaCI (04).3 M) in 0.01 M Tris buffer, 
pH 7.4. 
Abbreviations: -AMC, 4-methyl-7-coumarylamide; Bz-, benzoyl; Analytical isoelectric focusing of the inhibitors was performed on a 
Cm-, carboxymethyl-; CNBr, cyanogen bromide; Ep-475, L -3 -  Phastsystem apparatus (Pharmacia, Sweden). 
carboxy- trans-2, 3-epoxypropylleucylamido(3-guanidino)butane; 
HPLC, high-performance liquid chromatography; PAGE, polyacryl- 2.3. Sequence determination and amino acid analysis 
amide gel electrophoresis; PITC, phenylisothiocyanate; PLCPI, pig Stefin B was reduced with I]-mercaptoethanol at 37°C, overnight. 
leukocyte cysteine proteinase inhibitor; PTH, phenylthiohydantoin; The molecule was S-pyridylethylated as described [24]. Pyridylethyl- 
Z-, benzyloxycarbonyl- ated stefin B (PE-stefin B) was dissolved in 80% (v/v) HCOOH and a 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
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50-fold molar excess of CNBr over methionine residues was added. I ~~!~i~:~!~ ~ : ~: ,I 
After 61 h incubation at room temperature in the dark the reaction [ ~ :~ i~!~ ~!~ . ~  
was quenched with the addition of 5 vols. of twice-distilled water and ' '~'~ ...... : 
the protein freeze-dried. Native stefins D1 and D2 were cleaved with 8.45 - -  ~ i ~ ~ i! :~iii!~i{ 
CNBr in a similar manner. 8.1 5 - -  
Native stefin B was hydrolysed by glycyl endopeptidase as described . . . .  
[25]. The G2-peptide and stefins A and B were maleylated and dema- ii : !! !i)}!! I~I i!ii~il )i ill! i: 
leylated according to [26]. G2-peptide was also subjected 4to mild acid :~i: il :ili ii~i ! i ! ~  
hydrolysis in 80% (v/v) HCOOH at 37°C for 68 h. The reaction was 7.35 - -  ~ i: ii:i~ ~ii~: :~:~:' : !' 
andSt°ppedfreeze-drying.by dilutio  of the reaction mixture with twice-distilled water Ni~i :):,i~ i.: ~ 
Native stefins A and B were incubated with [3-trypsin in 0.1 M N- :~::' : ~  
methylmorpholine/acetate buff r, pH 8.11, at 37°C for 3 h. The en- :i~i: ! ;~:!i:: ii~ 
zyme was added in two portions to a final concentration f 4% (w/w). ~:.-'~ii~ . 
Maleylated stefin A and maleylated G2-peptide were fragmented 
using 2-4% (w/w) S. aureus V-8 proteinase in 0.1 M Na phosphate . . . .  ~ ~' ,:~ 
pH 7.8, at 37°C for 18-24 h. Reactions were stopped by acidification 5.85 - -  ~:::~i:!~ ~::'~!~:: ; 
with trifluoroacetic acid. E8-peptide, from S. aureus V-8 proteinase ~ < .~L 
fragmentation f stefin A, was further fragmented by ct-chymotrypsin. 
The same buffer as for tryptic digestion was used. The incubation time 5.20 - -  
was 2 h and the concentration of proteinase 4% (w/w). ~ b 
Peptide mixtures were separated by HPLC (Milton Roy, USA) 
using a reverse-phase, ChromSep C8, Vydac C18 or Aquapore RP- 4.55 -~ ~ ~ 
300 column equilibrated with 0.1% (v/v) trifluoroacetic acid in water. 
Elution was performed with various linear gradients of 80% (v/v) 
acetonitrile containing 0.1% (v/v) trifluoroacetic acid. Absorbance 3.50 - -  
was monitored at 215 nm. 
Protein samples were hydrolysed in 6.0 M HC1 at 110°C for 24 h. 
Peptide hydrolysates were analysed using an amino acid analyser Ap- 
plied Biosystems 421A (USA) with pre-column PITC derivatization. 1 2 3 4 5 6 
An Applied Biosystems (USA) liquid-pulse sequencer 475A, con- Fig. 1. Isoelectric focusing of the purifed inhibitors. Lanes: 1,6, 
nected on-line to a PTH analyser 120A from the same manufacturer, standards; 2, stefin A; 3, stefin B; 4, stefin D1; 5, stefin D2. 
was used for automated amino acid sequence analyses. 
Molecular mass analysis of N-terminally blocked Gl-peptide was 
accomplished on an Autospec Q mass spectrometer (VG-Analytical, 3. Results 
UK), using the fast atom bombardment ionization method. Glycerol 
was used as a matrix. 
3.1. Purification of  the inhibitors 
We isolated from porcine thymus and skin four different 
2.4. Kinetics of inhibition of cysteine proteinases 
For routine assays, the papain inhibitory activity of the samples cysteine proteinase inhibitors. This purif ication resulted in fi- 
was determined using Bz-oL-Arg-2 naphthylamide as substrate [27]. hal yields of 1.9 mg of stefin D1, 2.1 mg of stefin D2 and 2.5 
Active site titrations of papain, cathepsins B, L and S were performed mg of stefin B from 2 kg of porcine thymus and 1.8 mg of 
using cysteine proteinase inhibitor Ep-475, while cathepsin H was stefin A from 1.5 kg of porcine skin. 
active site titrated with stefin B, whose molarity was previously de- Analytical isoelectric focusing showed that all the inhibitors 
termined with active site titrated papain [12]. 
In all kinetic experiments, papain, cathepsins B, and S were assayed are acidic proteins, each exhibiting a single band (Fig. 1) (the 
using 0.1 M phosphate buffer, pH 6.0, containing 2 mM dithiothreitol second band in stefin B appears on storage). The following p l  
and 1.5 mM EDTA. For cathepsin H, 0.1 M phosphate buffer, pH values were determined: 4.6 for stefin D1, 4.5 for stefin D2, 
7.0, containing 2 mM dithiothreitol and 1.5 mM EDTA was used, 5.5 for stefin A and 5.0 for stefin B. 
while cathepsin L was assayed in 0.1 M acetate buffer, pH 5.5, con- 
taining 1.5 mM EDTA and 2 mM dithiothreitol. Continuous rate 
assays were used for kinetic analysis of the interactions of papain, 3.2. Sequence determination ofstefin A 
cathepsins B, H, L and S with stefins A, B and D2. Variable concen- Native stefin A was cleaved with trypsin, and T-peptides 
trations of inhibitors and substrates (5 gM Z-Phe-Arg-AMC for pa- were isolated and sequenced (Fig. 2a). The T12-13 peptide 
pain, 10 laM Z-Phe-Arg-AMC for cathepsins B and L, 20 gM Z-Phe- represented the C-terminus of the molecule, as Phe is not a 
Arg-AMC for cathepsin S and 10 gM Arg-AMC for cathepsin H) 
were dissolved in 1.97 ml of the appropriate buffer. The reaction was cleavage point for ~-trypsin. The second set of peptides was 
started by the addition of 20 gl of activated papain (380 pM final prepared using S. aureus V-8 proteinase which cleaves after 
concentration), cathepsin B (130 pM final concentration), cathepsin H Glu. Before digestion, stefin A was maleylated in order to 
(300 pM final concentration) or cathepsin S (200 pM final concentra- destroy the strong tertiary structure of the inhibitor and ex- 
tion), respectively. All experiments were performed under pseudo-frst 
order conditions, i.e. at a molar ratio of the inhibitors to enzymes of pose the cleavage sites. V-peptides resulted and their sequence 
10:1. The progress curves were monitored at excitation and emission analysis provided most of the overlaps (Fig. 2a). V7-8 peptide 
wavelengths of 370 and 460 rim, respectively, using a Perkin Elmer was very hydrophobic and only scarcely soluble. It was pur- 
LS-3 spectrofiuorimeter. Data were analysed by non-linear regression ified by washing the precipitate. The C-terminal sequence was 
analysis according to [28]. confirmed by V10-peptide which ended with Phe and not with 
The equilibrium dissociation constants for the interaction between 
stefn D2 with cathepsins B and H were determined using a stopped Glu. The last uncertainties in the structure were resolved by 
assay. Activated cathepsin B (130 nM fnal concentration) and cathep- subfragmentation of V7-8 peptide with ct-chymotrypsin and 
sin H (25 nM final concentration) were incubated for 20 min at 25°C analysis of the resulting CT-peptides. Porcine stefin A consists 
with inhibitors at various concentrations (50-750 nM final concentra- of 101 amino acid residues. Its Mr is 11 391. 
tions) in appropriate buffer. Residual activities of cathepsins B and H 
were determined under the same conditions as described previously 
[27] using BZ-DL-Arg-2 naphthylamide and Arg-2 naphthylamide, re- 3.3. Sequence determination ofstefin B 
spectively, as substrates. The N-terminal sequence analysis of the native molecule 
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Fig. 2. Amino acid sequences and strategies of the sequence determination of porcine stefin A (a) and stefin B (b). T- and Tr-peptides were ob- 
tained from trypsin cleavage, V- and E-peptides from S. aureus I/-8 proteinase hydrolysis, CT-peptides from chymotrypsin digestion, CN-pep- 
tides were derived from CNBr cleavage, G-peptides from glycyl endopeptidase hydrolysis, and A-peptides after acid hydrolysis. 
stefin B failed, suggesting that the molecule is N-terminally 3.4. Sequencing ofstefins D1 and D2 
blocked. However, after the reaction of PE-stefin B with By sequencing of peptides obtained after CNBr cleavage 
CNBr the sequence analysis was no longer prevented although and by amino acid analysis, we have shown that stefin D1 
the Mr of the protein remained virtually unchanged. In the is identical to PLCPI from porcine polymorphonuclear leuko- 
first sequencing cycle, in addition to PE-Cys, traces of Met cytes [14]. When N-terminal sequence analysis of native stefin 
were also identified, indicating the existence of two consecu- D2 was attempted no signal was obtained, indicating that its 
tive Met residues at the N-terminus of the peptide (peptide N-terminus is blocked. Following CNBr cleavage, however, 
CNI+CN2 in Fig. 2b). As Gly was found near the N-terminus the sequence of 36 amino acids, shown in Fig. 3, was estab- 
of stefin B, GIy-C endoproteinase was used for the fragmenta- lished. 
tion of native stefin B in order to generate the N-terminal 
peptide (G1). Besides Gl-peptide only one more peptide 3.5. Amino acid sequence comparison 
(G2) resulted from this reaction, representing the rest of the In Fig. 3 the amino acid sequences of stefins D1, D2, A and 
molecule. Mass spectrometry aswell as amino acid analysis of B are aligned with those of other mammalian stefin-type in- 
Gl-peptide revealed that its N-terminal amino acid residue hibitors. Pairwise comparisons for sequence identity between 
was N-acetylated. G2-peptide was exposed to mild acid hy- the members of the stefin family (Fig. 4) show 54-74% iden- 
drolysis and a low-yield cleavage of Asp62-Thr 6a was detected tity between members of the stefin A group and 71-85% be- 
(A2-peptide in Fig. 2b). The rest of G2-peptide was maley- tween members of the stefin B group. Sequence comparison of 
lated to achieve maximal unfolding and subcleaved with S. the N-terminal fragment of stefin D2 with other inhibitors 
aureus V-8 proteinase. The peptide mixture was demaleylated showed an extremely high proportion of identical residues 
and separated by HPLC. The peptides which were sequenced with porcine stefin D1 (90% in 36 residues, Fig. 3). The se- 
(E-peptides) are shown in Fig. 2. Peptide El0 represented the quence identity of stefin D1 with members of the stefin A and 
C-terminus of the molecule as it ended with Phe which is not a B type inhibitors is 51 79 and 54-57%, respectively. 
cleavage site of S. aureus V-8 proteinase. Tryptic cleavage of 
native stefin B provided peptides which were necessary to 3.6. Kinetics of  inhibition of  the cysteineproteinases 
solve the rest of the inhibitor structure (Tr-peptides in Fig. The rate constants of complex formation of papain, cathep- 
2b). Additional confirmation of the C-terminus was given by sin B, cathepsin H, cathepsins L and cathepsin S with stefin A, 
peptides Trl4 and Tr13-14. Porcine stefin B consists of 98 stefin B and stefin D2 were determined in pre-steady state 
amino acid residues. Its Mr is 11 174. experiments where the enzyme was added to a mixture of 
1 10 20  30  40  50  60 70  80  90 
pDI  I~  SEEMLAGGLTE PRPATPE I QE  IANKVKPQr  .~-~-KTNKTYEKFEAI  I YRS  QVVAGTNYY I K V H V ~  IR~S L ~ P ~  I GY  ~ K ~ D E L ~ F  
pD2 . . . . . . . . . . .  DT  . . . . . . . . . . . . . . . . . . .  K .D  
pA SDEI~IP~GLTEARPATPE I QE  ZATTVKSQ~.~R~TNKTYEKFEAVEYKS QVVAG I NYY  IKVHVGGNS YV l I IKVFKS ~ L S  GYQ~K~DEL~F 
hA .I . . . .  S . .K  . . . . . . . . .  VDK. .P  . . . . . . . . . .  G .L . . .Q . .T  . . . . .  T . . . . . .  RA .D.K .M.L  . . . . . . .  G . .ED.V .T  . . . . . .  N . . . . . . . .  
rot I~PGTTGIV .  ,VS . .K  . . . . . . . .  V .DK. .R  . . . . . . . .  K . . . .  KV  . . . . . . . . . .  Q ILFM. .D . .NG~FL .M. .  LRG.  SGDD-D.K .  LD. .TN. . .N  . . . .  D.  
hA  .I . . . . . . .  K . . . I  . . . . . .  NM. .P  . . . . . . . . . . .  E .T . I  . . . . . . . . . . . . . . .  IQT .D .R .  I . . . . . . . . .  Q.  SHS.  I .T  . . . . . . . . . . . .  A . .  
pB  I~ ICGAPSATQPATAE I QA IADKVKSQr  .~-~-W~NK~t~KAVE FKSQVVAGRNLF  I KVQVDDDD FVHLRVFE S L P ~ L ~  S S Y Q ~  EL~F 
hB . . . . . . . . . . . . . . .  T . I I . . .Q .R  . . . . . . . . .  K . . . . . . .  S . . . . . . . .  T .Y  . . . .  H .G .E  . . . . . . . .  Q . . . . . . . . . . . .  N . . . . .  AK  . . . . . . .  
r~  . . . . . . . . .  M . . .T .T .E  . . . . . . . . . . . .  A .QK.D . . . .  IS .RR . . . . .  T .F  . . . .  D.  GEEKC . . . . . .  EP  . . . . . . . . . . . . . . .  D .EK  . . . . . . .  
hB  . . . . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . .  K . . . . . .  L . . . . .  L . . .K .~ . . . . . . .  E . . . . .  I . . .E  . . . . . . . .  VA .T  . . . . . .  G ........ 
bC MWGPNLGGF SD TQDATAE I ~AIADQVKSqT-~-R I~U~'~A~ QVVAGI~IY L I KVQVDEDD FVII IRVFE S LPHENKPVALT S Y ~  EL~F 
Fig. 3. Alignment of the amino acid sequences of porcine stefins with those of other stefins, pD, porcine stefin D (pD1 is identical to PLCPI 
[14]); pA, porcine stefin A; hA, human stefin A; r~, rat cystatin tx; bA, bovine stefin A [13]; pB, porcine stefin B; hB, human stefin B; r[~, rat 
cystatin 13; bB, bovine stefin B [11]; bC, bovine stefin C [12]. Other references have been listed by Turk and Bode [3]. Dots denote the residues 
identical to those above (porcine stefins D1, A and B, respectively). 
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~¢ ~r¢ !hum ! nn i boy i~re i hu, ! tit i I~v I~ The higher Ki values for the interaction of cathepsins B and 
s tn l  stA i stA i¢/,s~ is  v, an [sts [c/,p i sm stC H with stefin D2 had to be determined by measuring the 
~reanl 79170 I 51 i 71 55157157 i 54 52 residual enzyme activities. From the plot of residual enzyme 
L ~_re_ ~Lt_~_  ' , , t_7_4_t__5_6_t_§7_ , , , activity versus concentration of the inhibitor, the Ki values __60_1_6_0_t__~__ ~ 57 53 were calculated using the modified Ackermann-Potter equa- 
, , t __53__1__53__b_53_ ~ 48 47 hum stA b_ -_ [ _ . _57_{__73__  ' ' J 
tion [33]. 
- rat e.e_L~ - -  . . . . . .  t____t____t__54__' ' - ' __51_I_._4_8 t __47_t '  ' ' 47 44 The kinetic constants, ka~s, kdiss and Ki are listed in Table 1. 
I I I 
bov lrOA I I i - 50 i 47 I 46 1 48 46 It is evident that all inhibitors are fast-acting and tight-bind- 
_~,_~__~B__ , , , _ _ - _~_s_4_ l __7_s_ ;  s5  79  ~-- -  ~- - -~- - - - ,  ing inhibitors of papain, cathepsin L and cathepsin S. The 
I I I I I I 
hu, , s tB  ~----t- - - -t -  . . . . . . .  f__-_l_Ta_~ 7S 72 markedly decreased affinities of stefin A and stefin B for ca- 
rat cLl~_ q , , , t i 71  65  . . . . . .  ~----t - - - -t -  . . . . . . .  I ---- I-- '--÷ thepsin B are primarily due to decreased values of kay. The 
I~wtB I' I' [ I' i I' 84 values of Ki for stefins D1 and D2 are so high that values of 
~wtc [ I l I ', I k~ could not be determined. The k~ is 40-fold lower for 
Fig. 4. Matrix of pair-wise sequence comparisons for amino acid se- stefin B than k~.~ for stefin A, whose k~s is still more than 
quences of the members of the stefin family. The percent of identity 10-fold lower than the values for other cathepsins or for pa- 
was calculated for all pairs of mammalian stefins from the number pain. Decreased affinity for cathepsin H was observed only 
of matched amino acids, porc stD1, porcine stefin which is identical with stefins D1 and D2, whereas stefins A and B bind rapidly 
to PLCPI [14]; porc stA, porcine stefin A; hum stA, human stefin and tightly to cathepsin H with Ki values more than 3 orders A; rat cyc4 rat cystatin c~; bov stA, bovine stefin A; porc stB, por- 
cine stefin B; hum stB, human stefin B; rat cy[~, rat cystatin ~; bov of magnitude lower. 
stB, bovine stefin B. 
4.  D iscuss ion  
the inhibitor and substrate. Release of the product was con- 
tinuously recorded and typical biphasic progress curves were Eight members of the stefin family [2] of mammalian cys- 
observed. Measurements were analysed by fitting the product teine proteinase inhibitors have been characterized on the 
release data to the integrated rate equation [28]. Linear de- protein level: human stefin A [6], human stefin B [8], rat 
pendence of the pseudo first-order ate constant on inhibitor cystatin ~ [34], rat cystatin [3 [35], bovine stefin A [13], bovine 
concentration was observed for all enzyme-inhibitor pairs stefin B [11], bovine stefin C [12] and PLCPI, a stefin-type 
investigated, k~ values were calculated from the slope of inhibitor isolated from porcine polymorphonuclear leukocytes 
the dependence of the pseudo-frst-order rate constant on in- [14]. All the inhibitors, except PLCPI, are members of stefin 
hibition concentration, using Km values of 2 gM for cathepsin A, B or C types. In this work we have isolated from porcine 
L [29], 11 gM for cathepsin S [30], 65 gM for papain [31] and thymus stefin B and two new, very closely related stefins, 
250 gM for cathepsin B [32] (Z-Phe-Arg-AMC) and 150 gM designated as stefins D1 and D2. Stefin D1 has been identified 
for cathepsin H [27] (Arg-AMC). kdiss values were calculated as the previously characterized PLCPI [14], while stefin A or 
for each inhibitor concentration. Ki values were calculated C type inhibitors were not detected in thymus. We isolated 
from k~, and kdiss, stefin A from porcine skin consistent with previous findings 
Table 1 
Kinetic and equilibrium data for the interaction between porcine cysteine proteinase inhibitors and papain and cathepsins B, H, L and S 
Enzyme Inhibitor kass (M -1 s -1) (X 10 6) kdiss (S -1) (× 104) Ki (nM) 
Papain stefin D1 1.00 + 0.31 1.90 + 0.39 0.190 + 0.097 a
stefin D2 8.60 + 1.21 3.62 + 0.26 0.042 + 0.009 
stefin A 4.31 + 1.32 7.49 _+ 0.63 0.174 + 0.066 
stefin B 21.68 + 2.82 26.84 + 2.50 0.124 + 0.027 
Cathepsin B stefin D1 N.D. N.D. 335 + 50 ~ 
stefin D2 N.D. N.D. 195 + 80 
stefin A 0.159+0.018 3.17+0.32 2 +0.42 
stefin B 0.004_+0.0004 3.35+0.29 84 _+ 15 
Cathepsin H stefin D1 N.D. N.D. 125 + 7 a 
stefin D2 N.D. N.D. 102 +_4 
stefin A 5.04 + 0.80 3.50_+ 0.05 0.069 + 0.012 
stefin B 0.70 + 0.05 0.19 + 0.01 0.027_+ 0.003 
Cathepsin L stefin D1 5.50 _+ 0.65 3.70 _+ 1.64 0.067 _+ 0.036 a
stefin D2 1.79 _+0.42 2.90_+0.27 0.161 _+0.051 
stefin A 38.42 _+ 7.09 7.74_+ 0.75 0.020 + 0.005 
stefin B 21.90 + 1.75 2.12 _+ 0.02 0.009 + 0.001 
Cathepsin S stefin D1 13.50 + 1.06 6.29 + 1.25 0.046 _+ 0.013 ~ 
stefin D2 11.15 _+ 1.04 4.16 _+ 0.56 0.037 + 0.008 
stefin A 6.83 _+ 0.38 3.61 _+ 0.13 0.053 _+ 0.004 
stefin B 8.28 + 1.90 7.45 _+ 0.80 0.090 _+ 0.029 
The experimental conditions are described in Sections 2 and 3. N.D., not determined. 
~Ki values are from [14]. 
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that human stefin A and rat cystatin c~ are present in high partially occupied by an octapeptide [48] that also interferes 
concentrations in various types of epithelial cells and poly- with the inhibitor binding. However, there are significant dif- 
morphonuclear g anulocytes [1,4,6,10]. ferences in the structure of cathepsin B and that of cathepsin 
The acidic pI value is a characteristic feature of stefins [5- H [18,48]. 
8,10 12]. Stefins B and D2 have blocked N-termini, while By contrast, similar kinetics of interaction between all ste- 
stefin D1 was found to have a partially open and stefin A a fins and cathepsins L and S and papain indicates that the 
completely free N-terminus. A blocked N-terminus is another negatively charged N-terminal extension of stefin D1 does 
characteristic feature of most inhibitors from the stefin family not interfere with enzyme binding. In addition, these results 
[8,12,25,34-36]. indicate that these enzymes have similar structures of the in- 
Pairwise comparison of sequence identity between inhibi- teracting regions. 
tors (Fig. 3) shows that porcine stefin A fits into the stefin These results uggest that beside the structural differences in 
A group as well as stefin B does into the stefin B group, the active site regions of the enzymes there are specific struc- 
Additionally, porcine stefin B appeared in both dimeric and tural determinants on the inhibitors that determine the speci- 
monomeric forms (data not shown), similar to rat [36], human ficity of inhibition. 
[8] and bovine stefin B [11]. The sequence identity between 
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